Tech Company Financing Transactions

RuiYi Funding Round

RuiYi closed a $13 million Series A venture capital round on 5/14/2009. Investors included Aravis Ventures, Merck Serono Ventures and SR One Capital Management.

Transaction Overview

Company Name
Announced On
5/14/2009
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
505 Coast Blvd S. 300
La Jolla, CA 92037
USA
Email Address
Overview
RuiYi is focused on the discovery and development of novel biologic therapeutics that meet the medical and commercial needs for China's patients and healthcare system and that have the potential to be disruptive globally.
Profile
RuiYi LinkedIn Company Profile
Social Media
RuiYi Company Twitter Account
Company News
RuiYi News
Facebook
RuiYi on Facebook
YouTube
RuiYi on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Paul Grayson
  Paul Grayson LinkedIn Profile  Paul Grayson Twitter Account  Paul Grayson News  Paul Grayson on Facebook
Founder
Andrew Schwab
  Andrew Schwab LinkedIn Profile  Andrew Schwab Twitter Account  Andrew Schwab News  Andrew Schwab on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/14/2009: Orasi Medical venture capital transaction
Next: 5/15/2009: SynapticMash venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary